Precision Genomics Collaboratory News

A team of Duke Health scientists have identified biomarkers that accurately identify numerous viral infections across the clinical stages of disease, advancing a potential new way to guide treatment, quarantine decisions, and other clinical and public health interventions in the setting of endemic and pandemic infectious diseases. 

For the first time at Duke, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, is awarding a Center of Excellence in Genome Science (CEGS) grant, to a group of Duke researchers, providing $14 million of research support over five years.

Duke researchers shared their reflections on the struggles and insights the process of research shutdown and reboot has had within their labs during a Virtual Research Town Hall.

The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, has selected two Duke University School of Medicine faculty to receive 2020 Genomic Innovator Awards. NHGRI honored a total of 12 early career investigators in genomics. Each awardee will receive five years of funding.

Thanks to a $250,000 grant from the Antibacterial Resistance Leadership Group, the RADICAL team has shifted its focus to examine whether their host gene expression test works for patients with COVID-19.

Svati Shah, MD, MHS, has been named Associate Dean of Genomics and Director of the Duke Precision Genomics Collaboratory. The collaboratory is a new coordinating center that will serve as the nexus for genetics and genomics activities in the School of Medicine. As director, Dr. Shah will coordinate efforts among institutes, centers and departments in all areas of genetics and genomics, ranging from fundamental basic science to clinical genomics and precision medicine.